Table 2 Univariate analysis of association between liver stiffness measurement (LSM) and other variables
| Â | Beta | 95% Confidentialinterval | P-value |
|---|---|---|---|
Demographic variables | Â | Â | Â |
Age, years | - 0.145 | - 0.054, 0.008 | 0.140 |
Body mass index, kg/m2 | 0.134 | - 0.041, 0.227 | 0.173 |
Disease duration, weeks | 0.090 | - 0.001, 0.004 | 0.362 |
Laboratory variables | Â | Â | Â |
C-reactive protein, mg/L | 0.051 | - 0.019, 0.032 | 0.608 |
Erythrocyte sedimentation rate, mm/hr | - 0.147 | - 0.026, 0.004 | 0.135 |
White blood cell, count/mm3 | - 0.071 | 0.000, 0.000 | 0.473 |
Hemoglobin, g/dL | 0.050 | - 0.232, 0.391 | 0.612 |
Platelet count, × 1,000/mm3 | - 0.044 | - 0.007, 0.004 | 0.654 |
Prothrombin time, INR | - 0.056 | - 6.729, 3.738 | 0.572 |
Glucose, mg/dL | 0.001 | - 0.034, 0.034 | 0.995 |
Blood urea nitrogen, mg/dL | - 0.045 | - 0.085, 0.053 | 0.651 |
Creatinine, mg/dL | - 0.061 | - 2.605, 1.358 | 0.534 |
Uric acid. mg/dL | 0.148 | - 0.058, 0.438 | 0.132 |
Aspartate aminotransferase, IU/L | 0.146 | - 0.014, 0.099 | 0.136 |
Alanine aminotransferase, IU/L | 0.131 | - 0.014, 0.071 | 0.183 |
Total protein, mg/dL | 0.002 | - 0.807, 0.822 | 0.985 |
Serum albumin, mg/dL | 0.089 | - 0.645, 1.741 | 0.364 |
Total bilirubin, mg/dL | - 0.048 | - 2.135, 1.299 | 0.630 |
Alkaline phosphatase, IU/L | - 0.372 | - 0.024, 0.017 | 0.711 |
Gamma-glutamyltranspeptidase, IU/L | 0.249 | 0.008, 0.058 | 0.010 |
Triglyceride, mg/dL | - 0.033 | - 0.007, 0.005 | 0.738 |
High density cholesterol, mg/dL | - 0.185 | - 0.050, - 0.001 | 0.059 |
Low density cholesterol, mg/dL | - 0.161 | - 0.022, 0.002 | 0.101 |
Cumulative dose of medication, mg | Â | Â | Â |
Methotrexate (105 patients) | 0.108 | 0.000, 0.000 | 0.273 |
Leflunomide (53 patients) | 0.285 | 0.000, 0.000 | 0.038 |
Sulfasalazine (82 patients) | 0.031 | 0.000, 0.000 | 0.782 |
Hydroxychloroquine (65 patients) | 0.072 | 0.000, 0.000 | 0.567 |
Prednisolone (89 patients) | 0.362 | 0.000, 0.000 | < 0.001 |
Meloxicam (90 patients) | - 0.012 | 0.000, 0.000 | 0.909 |
Celecoxib (70 patients) | 0.182 | 0.000, 0.000 | 0.131 |